Accretive Wealth Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$585K Hold
10,018
– – 0.12% 114
2026
Q2
$545K Hold
10,018
– – 0.13% 119
2026
Q1
$430K Sell
10,018
-132
-1% -$5.68K 0.12% 129
2025
Q4
$445K Hold
10,150
– – 0.13% 114
2025
Q3
$419K Hold
10,150
– – 0.13% 115
2025
Q2
$447K Hold
10,150
– – 0.15% 109
2025
Q1
$374K Sell
10,150
-650
-6% -$23.2K 0.13% 117
2024
Q4
$360K Sell
10,800
-800
-7% -$26K 0.15% 112
2024
Q3
$301K Hold
11,600
– – 0.13% 117
2024
Q2
$261K Hold
11,600
– – 0.11% 124
2024
Q1
$254K Buy
+11,600
New +$258K 0.11% 125

Other funds holding EXEL

Accretive Wealth Partners's EXEL Position: Q3 2026 in Review

Accretive Wealth Partners held its Exelixis (EXEL) position steady in Q3 2026 at 10,018 shares worth $585K. The position accounts for 0.12% of the portfolio, ranked #114.

Accretive Wealth Partners first reported a position in EXEL in Q1 2024 and has held it in 11 quarters since. 417 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • Accretive Wealth Partners held 10,018 shares of Exelixis worth $585K as of Q3 2026.
  • Accretive Wealth Partners left its Exelixis share count unchanged in Q3 2026.
  • Exelixis made up 0.12% of Accretive Wealth Partners's portfolio in Q3 2026, its #114 holding.
  • Accretive Wealth Partners first reported a position in Exelixis in Q1 2024 and has held it in 11 quarters since.
  • 417 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on Accretive Wealth Partners's 13F filing for Q3 2026, filed 6 Nov 2026.